Stay updated on ELVN-002 in HER2 NSCLC Clinical Trial

Sign up to get notified when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ELVN-002 in HER2 NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T12:51:19.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T09:33:09.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    This update changes the version to v3.0.2 and removes the 'Back to Top' label; no other substantive changes are present.
    Difference
    0.2%
    Check dated 2025-09-14T00:14:15.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T21:02:10.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of new medical terms and compounds. Notably, the drug Trastuzumab Emtansine has been emphasized, while previous mentions of related topics and certain locations have been removed.
    Difference
    10%
    Check dated 2025-08-30T15:32:07.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T12:13:30.000Z thumbnail image

Stay in the know with updates to ELVN-002 in HER2 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.